Press releases

• Jan 9, 2020Calliditas submits draft registration statement for the listing of ADSs in the U.S.
• Dec 23, 2019The pivotal Phase 3 clinical trial NefIgArd Part A fully recruited
• Dec 19, 2019Completion of recruitment of Part A of the NeflgArd pivotal Phase 3 clinical trial by year end

All press releases

Interim Report Q3 2019

On November 14, 2019, Calliditas Therapeutics published its business update for the third quarter 2019.

• Report
• Press release
• Presentation
• Audio cast

Read the report

Calendar

• Feb 14, 2020Year-end report for the period January 1 – December 31, 2019
• Mar 30, 2020 - Apr 3, 2020Annual Report
• May 14, 2020Annual general meeting 2020

All events